M&A Deal Summary

Kyphon Acquires St. Francis Medical Technologies

On December 4, 2006, Kyphon acquired medical products company St. Francis Medical Technologies from EW Healthcare Partners for 525M USD

Acquisition Highlights
  • This is Kyphon’s 1st transaction in the Medical Products sector.
  • This is Kyphon’s largest (disclosed) transaction.
  • This is Kyphon’s 1st transaction in the United States.
  • This is Kyphon’s 1st transaction in California.

M&A Deal Summary

Date 2006-12-04
Target St. Francis Medical Technologies
Sector Medical Products
Buyer(s) Kyphon
Sellers(s) EW Healthcare Partners
Deal Type Add-on Acquisition
Deal Value 525M USD

Target

St. Francis Medical Technologies

Alameda, California, United States
St. Francis Medical Technologies, Inc. manufactures the X-STOP Interspinous Process Decompression (IPD) System, the first FDA-approved interspinous process device for treating lumbar spinal stenosis.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Kyphon

Sunnyvale, California, United States

Category Company
Founded 1994
Sector Medical Products
DESCRIPTION

Kyphon, located in Sunnyvale, California, develops, manufactures and markets minimally invasive medical devices, which employ a proprietary balloon technology, to help surgeons repair spine fractures caused by osteoporosis, cancer and trauma. Approximately 700,000 of these fractures, also known as vertebral compression fractures ('VCF'), are diagnosed each year in the U.S. Left untreated, they can result in significant pain, deformity and reduced respiratory function, as well as shortened life expectancy


DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (2006) 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 1

SELLER

EW Healthcare Partners

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1985
PE ASSETS 3.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.


DEAL STATS #
Overall 9 of 53
Sector (Medical Products) 3 of 24
Type (Add-on Acquisition) 4 of 34
State (California) 3 of 17
Country (United States) 8 of 46
Year (2006) 4 of 4
Size (of disclosed) 4 of 22
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-07-18 Confluent Surgical

Waltham, Massachusetts, United States

Confluent Surgical, Inc.develops products to address the need for surgical sealing and post-surgical adhesion prevention applications.

Sell $245M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-01-01 Oraya Therapeutics

Newark, California, United States

Oraya Therapeutics is a privately held, development-stage medical technology company, pioneering noninvasive radiation treatments for inflammatory and neovascular diseases of the eye.

Buy -